When evaluating multiyear payment arrangements, it's important to assess retention rates for patients with rare diseases. This study found subscriber retention is high for adults diagnosed with a rare disease and excluding this assessment could lead to inaccurate expectations for health insurers and plan administrators.

This article was originally published by JMCP.